1. Table 4. Comparison of screening guidelines in terms of the total number and percentages of patients screened for ...
Table 4. Comparison of screening guidelines in terms of the total number and percentages of patients screened for inhalational anthrax (IA) and the associated charges.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.

2. Table 3. Clinical data extracted from emergency department records from 20 October 2001 through November 2001.
Table 3. Clinical data extracted from emergency department records from 20 October 2001 through November 2001.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.

3. Table 2. Number of patients presenting to emergency departments with clinical symptoms referable to acute pulmonary ...
Table 2. Number of patients presenting to emergency departments with clinical symptoms referable to acute pulmonary anthrax, with associated charges.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.

4. Table 1. International Classification of Disease, Ninth Revision (ICD-9), codes used to identify for review the ...
Table 1. International Classification of Disease, Ninth Revision (ICD-9), codes used to identify for review the records of patients presenting to emergency departments with possible cases of inhalational anthrax.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.

5. Figure 2. The Cornell protocol [2] applied to 1127 patients with symptoms of and/or exposure to inhalational anthrax ...
Figure 2. The Cornell protocol [2] applied to 1127 patients with symptoms of and/or exposure to inhalational anthrax (IA) presenting to emergency departments and evaluated during the 2001 bioterrorism-related outbreak of IA. IA pts, number of patients with documented inhalational anthrax; n, number of patients with symptoms of and/or exposure to IA.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.

6. Figure 1. Revisions to the Centers for Disease Control and Prevention interim guidelines. AMS, altered mental status; ...
Figure 1. Revisions to the Centers for Disease Control and Prevention interim guidelines. AMS, altered mental status; CXR, chest radiograph; HR, heart rate; IA, inhalational anthrax; LP, lumbar puncture; T, temperature. *Feature not previously known to be associated with IA. Adapted and expanded from [2].
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2004 by the Infectious Diseases Society of America
Clin Infect Dis, Volume 39, Issue 12, 15 December 2004, Pages 1842–1847,
The content of this slide may be subject to copyright: please see the slide notes for details.